Linna Wang

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

Shukui Qin, Zhenggang Ren, Zhiqiang Meng et al. · The Lancet Oncology · 2020 · 625 citations

Hepatology, Medicine, Pathology +6

Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial

Feng Wang, Shukui Qin, Xinchen Sun et al. · Journal of Hematology & Oncology · 2020 · 132 citations · Full text

Multicenter Phase 2, Immunology, Pathology +21

Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Zhi Peng, Jia Wei, Wang Feng et al. · Clinical Cancer Research · 2021 · 113 citations · Full text

Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial

Dan Liu, Jun Zhou, Yongsheng Wang et al. · BMC Medicine · 2022 · 73 citations · Full text

Calcium-dependent activation of CPK12 facilitates its cytoplasm-to-nucleus translocation to potentiate plant hypoxia sensing by phosphorylating ERF-VII transcription factors

Biao Fan, Ke Liao, Linna Wang et al. · Molecular Plant · 2023 · 73 citations · Full text

Transcriptional Regulation, Signal Transduction, Signaling Pathway +13